Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hall Samuel W. — Stoke Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Hall Samuel W.

Hall Samuel W.

Director at Stoke Therapeutics, Inc. · on record since Jun 18, 2019
10% owner at Stoke Therapeutics, Inc. · on record since Sep 12, 2019

Insider trading activity of Hall Samuel W.

Transactions on record: 1; since Sep 12, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Sep 12, 2019

Figures computed from official regulatory filings — methodology.

Companies where Hall Samuel W. has traded

Stoke Therapeutics, Inc.1 tx · Sep 12, 2019

Track record of Hall Samuel W.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hall Samuel W.

Co-insiders of Hall Samuel W.

Allan JonathanStoke Therapeutics, Inc.
Apple Tree Partners IV, L.P.Stoke Therapeutics, Inc.
ATP III GP, Ltd.Stoke Therapeutics, Inc.
Blue Horizon Enterprise LtdStoke Therapeutics, Inc.
Burstein JenniferStoke Therapeutics, Inc.
Ezbon International LtdStoke Therapeutics, Inc.
Green JeremyStoke Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Harrison Seth LoringStoke Therapeutics, Inc.

Hoitt JasonStoke Therapeutics, Inc.

Kahn ClareStoke Therapeutics, Inc.

Kaye Edward M. MDStoke Therapeutics, Inc.

Krainer Adrian R.Stoke Therapeutics, Inc.

Leggett ThomasStoke Therapeutics, Inc.

LEVIN ARTHUR AStoke Therapeutics, Inc.

Liau GeneStoke Therapeutics, Inc.

Menzel Garry EStoke Therapeutics, Inc.

Montrago Trustees LtdStoke Therapeutics, Inc.

Nash Huw M.Stoke Therapeutics, Inc.

Redmile Group, LLCStoke Therapeutics, Inc.

RTW INVESTMENTS, LPStoke Therapeutics, Inc.

Skorpios TrustStoke Therapeutics, Inc.

SMITH IAN FStoke Therapeutics, Inc.

Smith JulieStoke Therapeutics, Inc.

Ticho BarryStoke Therapeutics, Inc.

Tulipano Stephen JStoke Therapeutics, Inc.

TZIANABOS ARTHURStoke Therapeutics, Inc.

Walker Robin A.Stoke Therapeutics, Inc.

WONG RODERICKStoke Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Stoke Therapeutics, Inc.	Sep 12, 2019	AwardD	29,555	0.00 USD	$0	SEC